PSK2 Polyclonal Antibody
Product Specifications
Background
TAK1 is a mitogen-activated protein kinase kinase kinase that can be activated by TGF-β, bone morphogenetic protein and other cytokines including IL-1. In vivo activation of TAK1 requires association with TAK1 binding protein 1 (TAB1), which triggers phosphorylation of TAK1. Another adaptor protein, TAB2, links TAK1 with TRAF6 and mediates TAK1 activation upon IL-1 stimulation. Once activated, TAK1 phosphorylates MAPK kinases MKK4 and MKK3/6, which activate p38 MAPK and JNK, respectively. In addition, TAK1 activates the NF-κB pathway by interacting with TRAF6 and phosphorylating the NF-κB inducing kinase (NIK).
CAS Number
9007-83-4
Synonyms
TAOK1; KIAA1361; MAP3K16; MARKK; Serine/threonine-protein kinase TAO1; Kinase from chicken homolog B; hKFC-B; MARK Kinase; MARKK; Prostate-derived sterile 20-like kinase 2; PSK-2; PSK2; Prostate-deriv
Host
Rabbit
Reactivity
Human;Mouse;Rat
Immunogen
The antiserum was produced against synthesized peptide derived from human TAOK1. AA range:431-480
Clonality
Polyclonal
Applications
WB, IHC-p, ELISA
Stability
-20°C for one year
Concentration
1 mg/ml
Molecular Weight
116070
Antibody Type
Primary antibody
Isotype
IgG
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
036998-ML650 100 µL
IL23R, CT (IL23R, Interleukin-23 receptor) (MaxLight 650) discontinued
Sign In for Pricing
View Details 
OM11002-01 2 mg
4-Methoxyphenyl 4-O- (3,6-di-O-benzyl-2-deoxy-4-O-levulinoyl-2-phthalimido-b-D-glucopyranosyl) -3-O-benzyl-6-O-tert-butyldimethylsilyl -2-deoxy-2-phthalimido-b-D-glucopyranoside
Sign In for Pricing
View Details